A miracle drug of hepatitis C in the process of curing thousands of people in Australia from liver disease



[ad_1]

A medicine that cures hepatitis C will be available for thousands of Australians this week.

The revolutionary drug Maviret must be listed on the federal government's pharmaceutical benefits program on Wednesday.

The cost of the drug will be reduced from the current price per treatment of $ 50,000 to only $ 39.50 or $ 6.40 for dealers, Seven News .

New drug cures 90% of patients who undergo treatment for fatal liver disease

  A drug that cures hepatitis C will be available for thousands of Australians over this week [19659006] A drug that will cure hepatitis C

A medicine that cures hepatitis C will be available for thousands of Australians as of this week

Hepatitis C is transmitted from blood to blood contact, including sharing of medicated material, resulting in swelling of the liver, liver failure and sometimes cancer.

Melbourne busker Stephen Twohig told the network that he thought he was going to die of the disease until he was sued for the drug.

"I had pain in the liver, and it was due to cirrhosis," he said.

"I always thought I would die of hepatitis C."

  Hepatitis C is transmitted from blood to blood, including the sharing of medicated material, resulting in swelling of the liver, liver failure and sometimes cancer (stock photo)

<img id = "i -62f946c499f1ea66 "src =" https://i.dailymail.co.uk/i/newpix/2018/07/29/12/4EAAB3C600000578-0-image-a-25_1532863091654.jpg "height =" 423 "width =" 634 "alt =" Hepatitis C is transmitted from blood to blood The hepatitis C is transmitted from blood to blood contact, including the sharing of equipment of the drug, which leads to a liver swelling, liver failure, and sometimes cancer (photo stock)

Health Minister Greg Hunt told the network that he hopes the disease will be cured in Australia.

"We want to be the first big country in the world to eradicate hepatitis C, and that's our chance, "he said.

The drug contains two antiviral agents that prevent the virus from multiplying and spreading to new cells.

Professor Gregory Dore, director of the Clinical Research Program on Viral Hepatitis at the Kirby Institute, also hoped that PBS enrollment would help eliminate the disease.

  Melbourne busker Stephen Twohig (pictured) thought he was going to die of the disease until he went on trial for the drug.

 Melbourne busker Stephen Twohig (pictured) thought he was going to die of illness until he underwent a trial for the drug.

Melbourne busker Stephen Twohig (pictured) thought that he was going to die of illness until he had undergone an essay for the drug.

"The inclusion of Maviret on the PBS provides an additional tool in the strategy to eliminate hepatitis C as a threat to public health in Australia and around the world," he said. he declared to the AAP.

"For people living with hepatitis C, especially those who are new to treatment, this new plan offers another treatment option.

[ad_2]
Source link